首页> 外文期刊>Journal of Medical Physics/Association of Medical Physicists of India >Validation of PRIMO Monte Carlo Model of Clinac?iX 6MV Photon Beam
【24h】

Validation of PRIMO Monte Carlo Model of Clinac?iX 6MV Photon Beam

机译:验证Primo Monte Carlo模型的Clinac?IX 6MV光子梁

获取原文
           

摘要

Purpose: This study aims to model 6MV photon of Clinacsup?/supiX linear accelerator using PRIMO Monte Carlo (MC) code and to assess PRIMO as an independent MC-based dose verification and quality assurance tool. Materials and Methods: The modeling of Clinacsup?/supiX linear accelerator has been carried out by using PRIMO simulation software (Version 0.3.1.1681). The simulated beam parameters were compared against the measured beam data of the Clinacsup?/supiX machine. The PRIMO simulation model of Clinacsup?/supiX was also validated against Eclipsesup?/sup Acuros XB dose calculations in the case of both homogenous and inhomogeneous mediums. The gamma analysis method with the acceptance criteria of 2%, 2 mm was used for the comparison of dose distributions. Results: Gamma analysis shows a minimum pass percentage of 99% for depth dose curves and 95.4% for beam profiles. The beam quality index and output factors and absolute point dose show good agreement with measurements. The validation of PRIMO dose calculations, in both homogeneous and inhomogeneous medium, against Acurossup?/sup XB shows a minimum gamma analysis pass rate of 99%. Conclusions: This study shows that the research software PRIMO can be used as a treatment planning system-independent quality assurance and dose verification tool in daily clinical practice. Further validation will be performed with different energies, complex multileaf collimators fields, and with dynamic treatment fields.
机译:目的:本研究旨在使用Primo Monte Carlo(MC)代码为6MV光子Clinac IX线性加速器,并评估Primo作为基于独立的MC的剂量验证和质量保证工具。材料和方法:通过使用Primo仿真软件(版本0.3.1.1681)进行了Clinac Δ ix线性加速器的建模。将模拟光束参数与Clarac IX机器的测量光束数据进行比较。 Clinac β Ix的Primo仿真模型也验证了Eclipse αs≤zh_cn_capsth_caps'scumosxb剂量计算,在均匀和不均匀介质的情况下。伽马分析方法具有2%,2mm的验收标准用于对剂量分布的比较。结果:伽玛分析显示深度剂量曲线的最小通行率为99%,梁轮廓为95.4%。光束质量指数和输出因子和绝对点剂量显示出良好的测量协议。对均匀和不均匀介质的Primo剂量计算验证对抗Acuros β〜xb显示最小γ分析率为99%。结论:本研究表明,研究软件PRIMO可作为日常临床实践中的治疗计划系统独立的质量保证和剂量验证工具。将使用不同的能量,复杂的多叶准直器字段和动态处理领域进行进一步验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号